[go: up one dir, main page]

AU1444095A - Water soluble non-immunogenic polyamide cross-linking agents - Google Patents

Water soluble non-immunogenic polyamide cross-linking agents

Info

Publication number
AU1444095A
AU1444095A AU14440/95A AU1444095A AU1444095A AU 1444095 A AU1444095 A AU 1444095A AU 14440/95 A AU14440/95 A AU 14440/95A AU 1444095 A AU1444095 A AU 1444095A AU 1444095 A AU1444095 A AU 1444095A
Authority
AU
Australia
Prior art keywords
immunogenic
water soluble
linking agents
soluble non
polyamide cross
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU14440/95A
Inventor
Tom That Hai
Deanna J. Nelson
David Eugene Pereira
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Baxter International Inc
Original Assignee
Baxter International Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter International Inc filed Critical Baxter International Inc
Publication of AU1444095A publication Critical patent/AU1444095A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G69/00—Macromolecular compounds obtained by reactions forming a carboxylic amide link in the main chain of the macromolecule
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F8/00—Chemical modification by after-treatment
    • C08F8/30—Introducing nitrogen atoms or nitrogen-containing groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Polyamides (AREA)
  • Medicinal Preparation (AREA)
AU14440/95A 1993-12-27 1994-12-20 Water soluble non-immunogenic polyamide cross-linking agents Abandoned AU1444095A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US17388293A 1993-12-27 1993-12-27
US173882 1993-12-27
PCT/US1994/014821 WO1995017886A1 (en) 1993-12-27 1994-12-20 Water soluble non-immunogenic polyamide cross-linking agents

Publications (1)

Publication Number Publication Date
AU1444095A true AU1444095A (en) 1995-07-17

Family

ID=22633907

Family Applications (1)

Application Number Title Priority Date Filing Date
AU14440/95A Abandoned AU1444095A (en) 1993-12-27 1994-12-20 Water soluble non-immunogenic polyamide cross-linking agents

Country Status (5)

Country Link
EP (1) EP0702553A1 (en)
JP (1) JPH08507549A (en)
AU (1) AU1444095A (en)
CA (1) CA2156924A1 (en)
WO (1) WO1995017886A1 (en)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2351739A1 (en) * 1998-08-28 2000-03-09 Gryphon Sciences Polyamide chains of precise length, methods to manufacture them and their conjugates with proteins
EP1400551B1 (en) * 1998-08-28 2007-06-13 Amylin Pharmaceuticals, Inc. Polyamide chains of precise length and their conjugates with proteins
NZ598962A (en) 2009-09-16 2014-12-24 Genentech Inc Coiled coil and/or tether containing protein complexes and uses thereof
AR080793A1 (en) 2010-03-26 2012-05-09 Roche Glycart Ag BISPECIFIC ANTIBODIES
SG191153A1 (en) 2010-12-23 2013-07-31 Hoffmann La Roche Polypeptide-polynucleotide-complex and its use in targeted effector moiety delivery
CN103596984B (en) 2011-06-15 2016-04-13 霍夫曼-拉罗奇有限公司 The antibody of Anti-human EPO receptor and using method
EP2812357B1 (en) 2012-02-10 2020-11-04 F.Hoffmann-La Roche Ag Single-chain antibodies and other heteromultimers
CA2871880A1 (en) 2012-06-27 2014-01-03 F. Hoffmann-La Roche Ag Method for selection and production of tailor-made highly selective and multi-specific targeting entities containing at least two different binding entities and uses thereof
KR20150030744A (en) 2012-06-27 2015-03-20 에프. 호프만-라 로슈 아게 Method for making antibody fc-region conjugates comprising at least one binding entity that specifically binds to a target and uses thereof
CN104395340B9 (en) 2012-06-27 2018-11-30 弗·哈夫曼-拉罗切有限公司 Methods of customizing selective and multispecific therapeutic molecules comprising at least two different targeting entities and uses thereof
KR101923326B1 (en) 2014-06-06 2018-11-29 브리스톨-마이어스 스큅 컴퍼니 Antibodies against glucocorticoid-induced tumor necrosis factor receptor (gitr) and uses thereof
TN2017000203A1 (en) 2014-11-21 2018-10-19 Bristol Myers Squibb Co Antibodies against cd73 and uses thereof
CN107406494B (en) 2014-11-25 2022-03-25 百时美施贵宝公司 Novel PD-L1-binding peptides for imaging
CN107001482B (en) 2014-12-03 2021-06-15 豪夫迈·罗氏有限公司 Multispecific antibodies
CA2971542A1 (en) 2014-12-19 2016-06-23 Regenesance B.V. Antibodies that bind human c6 and uses thereof
US10983128B2 (en) 2015-02-05 2021-04-20 Bristol-Myers Squibb Company CXCL11 and SMICA as predictive biomarkers for efficacy of anti-CTLA4 immunotherapy
JP6797137B2 (en) 2015-05-29 2020-12-09 ブリストル−マイヤーズ スクイブ カンパニーＢｒｉｓｔｏｌ−Ｍｙｅｒｓ Ｓｑｕｉｂｂ Ｃｏｍｐａｎｙ Antibodies to OX40 and its use
BR112018010172A2 (en) 2015-11-19 2018-11-21 Bristol Myers Squibb Co antibodies to glucocorticoid-induced tumor necrosis factor receptor (gitr) and their uses
SG11201806861SA (en) 2016-03-04 2018-09-27 Bristol Myers Squibb Co Combination therapy with anti-cd73 antibodies
KR102397783B1 (en) 2016-06-01 2022-05-12 브리스톨-마이어스 스큅 컴퍼니 PET Imaging with PD-L1 Binding Polypeptides
MY200602A (en) 2016-07-14 2024-01-04 Bristol Myers Squibb Co Antibodies against tim3 and uses thereof
AU2017353939B2 (en) 2016-11-07 2025-01-30 Neuracle Science Co., Ltd. Anti-family with sequence similarity 19, member A5 antibodies and method of use thereof
SG11201906947SA (en) 2017-02-17 2019-08-27 Bristol Myers Squibb Co Antibodies to alpha-synuclein and uses thereof
WO2019075090A1 (en) 2017-10-10 2019-04-18 Tilos Therapeutics, Inc. Anti-lap antibodies and uses thereof
US12129297B2 (en) 2018-01-12 2024-10-29 Bristol-Myers Squibb Company Antibodies against TIM3 and uses thereof
PE20210665A1 (en) 2018-03-23 2021-03-31 Bristol Myers Squibb Co ANTIBODIES AGAINST MICA AND / OR MICB AND ITS USES
SG11202009625WA (en) 2018-04-02 2020-10-29 Bristol Myers Squibb Co Anti-trem-1 antibodies and uses thereof
KR102661891B1 (en) 2018-05-10 2024-05-23 주식회사 뉴라클사이언스 Anti-family with sequence similarity 19, member A5 antibody and methods of use thereof
WO2020003210A1 (en) 2018-06-29 2020-01-02 Kangwon National University University-Industry Cooperation Foundation Anti-l1cam antibodies and uses thereof
TW202035445A (en) 2018-10-10 2020-10-01 美商帝洛斯療法股份有限公司 Anti-lap antibody variants and uses thereof
US12139551B2 (en) 2018-12-03 2024-11-12 Bristol-Myers Squibb Company Anti-IDO antibody and uses thereof
MX2021008796A (en) 2019-01-22 2021-11-12 Bristol Myers Squibb Co Antibodies against il-7r alpha subunit and uses thereof.
CN118546253A (en) 2019-07-15 2024-08-27 百时美施贵宝公司 Antibodies against human TREM-1 and uses thereof
JP2022540674A (en) 2019-07-15 2022-09-16 ブリストル－マイヤーズ スクイブ カンパニー ANTI-TREM-1 ANTIBODY AND USES THEREOF
WO2021207449A1 (en) 2020-04-09 2021-10-14 Merck Sharp & Dohme Corp. Affinity matured anti-lap antibodies and uses thereof
US20240376224A1 (en) 2021-04-02 2024-11-14 The Regents Of The University Of California Antibodies against cleaved cdcp1 and uses thereof
WO2025010272A1 (en) 2023-07-03 2025-01-09 Neoimmunetech, Inc. Heterodimeric fc molecules and uses thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4168602A (en) * 1975-03-11 1979-09-25 Sun Ventures, Inc. Block copolymer of poly (dioxaarylamide) and polyamide and fibers and fibrous material produced therefrom
US5053520A (en) * 1988-09-22 1991-10-01 Abbott Laboratories Heterobifunctional maleimido containing coupling agents

Also Published As

Publication number Publication date
EP0702553A4 (en) 1996-01-19
JPH08507549A (en) 1996-08-13
WO1995017886A1 (en) 1995-07-06
EP0702553A1 (en) 1996-03-27
CA2156924A1 (en) 1995-07-06

Similar Documents

Publication Publication Date Title
AU1444095A (en) Water soluble non-immunogenic polyamide cross-linking agents
GB2285048B (en) Addition polymer
EP0655808A3 (en) Patch connector.
GR3032538T3 (en) Anti-fouling agent
AU1782495A (en) Encapsulation with water soluble polymer
DE59803995D1 (en) 32 p- polyphosphazen - radioaktiv markiertes antithrombogenes polymer
GB2275638B (en) Improvements in sprayers
AU3349593A (en) Polymeric tanning agents
GB2283790B (en) Pump
AU666351B2 (en) Water soluble polymers
GB9320610D0 (en) Water soluble retinoids
AU1321297A (en) Highly branched polymers
GB9523581D0 (en) Cross-linking
GB9201240D0 (en) Conjugated polymer
IL107715A0 (en) Water soluble non-immunogenic polyamide cross-linking agents
AU120203S (en) Pump
AU4706693A (en) Polymeric anticalculus agents
IL125063A0 (en) Water soluble antibiotics
AU681415B2 (en) Flood washing system
AU6391594A (en) Polymeric adamantane analogues
AU799P (en) STAR-STRUCK Thuja occidentalis
GB9622779D0 (en) Motor-vehicle anti-son sprinkler
GB2601717B (en) Towed buoys
AUPM313293A0 (en) Wash 'n' water
AUPN633095A0 (en) The loop line